You're contacting media contact of this press release

Title: CoreAgeRx Announces Advanced NAD+ Protocols for Cellular Energy, Cognitive Support, and Systemic Recovery

Sheridan, WY, United States, 22nd Aug 2026 - To address the cellular decline naturally associated with aging, CoreAgeRx has expanded its digital health platform to include two new biological support treatments. The company officially launched its NAD+ Injectable and NAD+ Nasal Spray therapies today, establishing a dedicated Energy and Recovery protocol designed to optimize mitochondrial function, mental clarity, and metabolic health.Nicotinamide Adenine Dinucleotide (NAD+) is a vital coenzyme present in every human cell. It plays a foundational role in energy metabolism, DNA repair, and healthy cellular aging. Biological aging systematically depletes NAD+ levels, a process that contributes directly to chronic fatigue, systemic inflammation, cognitive decline, and metabolic dysfunction. CoreAgeRx developed these new protocols to restore these critical coenzyme levels through efficient, science-backed delivery systems that provide comprehensive brain and body support.Both the injectable and nasal spray protocols start at $93 per month. CoreAgeRx delivers these treatments through a fully online concierge model featuring confidential consultations with US board-certified doctors. The medications are compounded exclusively in the USA by trusted partner pharmacies. Patients receive fast, free delivery directly to their homes without the requirement of long-term contracts.The NAD+ Nasal Spray offers a fast-acting formulation optimized for neurological support. By utilizing an intranasal route, the therapy bypasses the digestive system and the blood-brain barrier to deliver the coenzyme directly to the brain. This rapid delivery method provides profound neuroprotective effects, supporting mitochondrial function and DNA repair while remaining safe for long-term use with minimal...

This press release is issued by King Newswire